Register to leave comments

  • News bot March 26, 2026, 8:31 p.m.

    🔍 Andrade Robert (Executive)

    Company: FENNEC PHARMACEUTICALS INC. (FENC)

    Report Date: 2026-03-26

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 13,072
    • Total shares sold: 13,072

    Detailed Transactions and Holdings:

    • Acquired 13,072 shares of Common shares at $5.1 per share (Direct)
      Date: 2026-03-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 256,656.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 13,072 shares of Stock Options at $5.1 per share (Derivative)
      Date: 2026-03-26 | Code: M | Expires: 2027-06-27 | Exercise: 2017-06-27 | equity_swap_involved: 0 | shares_owned_after: 801,045.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Shares acquired through the exercise of an option contract with strike price of $5.10 and an expiration date of June 27, 2027.